Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abeona, Adial, Asceneuron, Aura, Betta, Botanix, Brickell, Cero, Cognition, Eyepoint, Helsinn, Juniper, Nordic Nanovector, Spero.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Axsome, Biogen, Coherus, Horizon, Hutchmed, Ideaya, Junshi, Moderna, Myovant, Novavax, Regeneron, Sage, Supernus, Vaxxinity, Vertex, Vitti.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Aptorum, Kala, Milestone, Sorrento, Tarsus, Vertex, Zynerba.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bristol Myers Squibb, Finch, Gilead, Merck, Moderna, Pfizer.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Denali, First Wave, Galera, Innate, Lyra, Novo Nordisk, Rezolute, Roche, Stealth, Timber.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Beigene, Cara, CNS, Janssen, Jasper, Moderna, Mycovia, Nevakar, SQZ, Timber, Vifor, Xbiotech.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, ABVC, Alzinova, Anaptysbio, Arecor, Beigene, Bioinvent, Delpor, Edesa, Eli Lilly, Galmed, Hibercell, Hightide, Ocuphire, Opiant, Transcenta, Tryp, Turning Point, Vaxxinity, Virios, Zymeworks.